Detalhe da pesquisa
1.
Genetically proxied interleukin-6 receptor inhibition increases risk of atopic dermatitis.
J Allergy Clin Immunol
; 2024 May 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38801923
2.
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Br J Dermatol
; 190(5): 689-700, 2024 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38051972
3.
Comparing binary efficacy outcomes for systemic immunomodulatory treatments for atopic dermatitis in a living systematic review and network meta-analysis.
Br J Dermatol
; 190(2): 184-190, 2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37831594
4.
Risk of serious infection and infection mortality in patients with psoriasis: A nationwide cohort study using the Taiwan National Health Insurance claims database.
J Eur Acad Dermatol Venereol
; 38(1): 136-144, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37611288
5.
The predictive accuracy of cardiovascular risk prediction tools in inflammatory arthritis and psoriasis: an observational validation study using the Clinical Practice Research Datalink.
Rheumatology (Oxford)
; 2023 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37966910
6.
Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR).
Br J Dermatol
; 189(1): 62-70, 2023 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37016153
7.
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Br J Dermatol
; 189(3): 271-278, 2023 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37226927
8.
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR.
Br J Dermatol
; 188(5): 618-627, 2023 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36763783
9.
The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study.
Br J Dermatol
; 188(4): 542-551, 2023 03 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36695406
10.
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey.
Br J Dermatol
; 188(5): 610-617, 2023 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36763806
11.
Systematic review and critical appraisal of psoriasis clinical practice guidelines: a Global Guidelines in Dermatology Mapping Project (GUIDEMAP).
Br J Dermatol
; 187(2): 178-187, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35152404
12.
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
J Allergy Clin Immunol
; 147(1): 60-71, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33075408
13.
A sprinkle of methotrexate to go with biologics: a safe recipe?
Br J Dermatol
; 190(3): 302-303, 2024 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38170214
14.
Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case-control study.
Br J Dermatol
; 190(3): 441-444, 2024 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37952181
15.
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update.
Br J Dermatol
; 190(2): 270-272, 2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37740557
16.
International melanoma and non-melanoma skin cancer mortality trends - is it time to re-focus our attention?
Clin Exp Dermatol
; 2023 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38060677
17.
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey.
Br J Dermatol
; 187(2): 254-256, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35104366
18.
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
Health Technol Assess
; 28(4): 1-113, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38343072
19.
Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis.
JAMA Dermatol
; 160(1): 71-79, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38055239
20.
Association of Lipid-Lowering Drugs With Risk of Psoriasis: A Mendelian Randomization Study.
JAMA Dermatol
; 159(3): 275-280, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36696131